Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Johan Rasmuson is active.

Publication


Featured researches published by Johan Rasmuson.


European Journal of Clinical Microbiology & Infectious Diseases | 2011

Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus

Johan Rasmuson; Charlotta Andersson; Eva Norrman; Michael Haney; Magnus Evander; Clas Ahlm

Hantaviruses have previously been recognised to cause two separate syndromes: hemorrhagic fever with renal syndrome in Eurasia, and hantavirus pulmonary syndrome (HPS) in the Americas. However, increasing evidence suggests that this dichotomy is no longer fruitful when recognising human hantavirus disease and understanding the pathogenesis. Herein are presented three cases of severe European Puumala hantavirus infection that meet the HPS case definition. The clinical and pathological findings were similar to those found in American hantavirus patients. Consequently, hantavirus infection should be considered as a cause of acute respiratory distress in all endemic areas worldwide.


Journal of Medical Virology | 2011

Hantavirus-specific IgA in saliva and viral antigen in the parotid gland in patients with hemorrhagic fever with renal syndrome

Lisa Pettersson; Johan Rasmuson; Charlotta Andersson; Clas Ahlm; Magnus Evander

The Hantavirus genus comprises rodent borne, zoonotic viruses of the Bunyaviridae family that cause hemorrhagic fever with renal syndrome (HFRS) in Eurasia and hantavirus cardiopulmonary syndrome (HCPS) in the Americas. Rodent saliva contains infectious hantavirus and evidence suggests that hantavirus is also shed in human saliva, but person‐to‐person transmission is rare. In saliva, immunoglobulin (Ig) A is the predominant immunoglobulin class. Secretory IgA serves as an important first line of defence on epithelial surfaces and the binding of secretory IgA to pathogens can inhibit adherence of microorganisms to mucosal cells and neutralize viruses. This study investigated the presence and importance of salivary IgA in relation to viral antigen in the saliva by testing Puumala hantavirus (PUUV) specific IgA, and RNA in saliva in acutely ill patients with HFRS. In saliva samples, PUUV specific IgA was detected in 12 of 33 (36%) patients with HFRS and 20 (61%) were PUUV RNA positive. There was a statistically significant inverse association between the presence of salivary IgA antibodies and PUUV RNA in the saliva. PUUV‐specific IgA in saliva was not found in a long‐term follow‐up, while PUUV IgA in serum was detected in three patients, 28–32 months after the initial study. Notably, both PUUV RNA and PUUV nucleocapsid antigen were detected in endothelial cells within the parotid gland of a deceased patient with HFRS. J. Med. Virol. 83:864–870, 2011.


PLOS Pathogens | 2017

Human hantavirus infection elicits pronounced redistribution of mononuclear phagocytes in peripheral blood and airways

Saskia Scholz; Faezzah Baharom; Gregory Rankin; Kimia T. Maleki; Shawon Gupta; Sindhu Vangeti; Jamshid Pourazar; Andrea Discacciati; Jonas Höijer; Matteo Bottai; Niklas K. Björkström; Johan Rasmuson; Magnus Evander; Anders Blomberg; Hans-Gustaf Ljunggren; Jonas Klingström; Clas Ahlm; Anna Smed-Sörensen

Hantaviruses infect humans via inhalation of virus-contaminated rodent excreta. Infection can cause severe disease with up to 40% mortality depending on the viral strain. The virus primarily targets the vascular endothelium without direct cytopathic effects. Instead, exaggerated immune responses may inadvertently contribute to disease development. Mononuclear phagocytes (MNPs), including monocytes and dendritic cells (DCs), orchestrate the adaptive immune responses. Since hantaviruses are transmitted via inhalation, studying immunological events in the airways is of importance to understand the processes leading to immunopathogenesis. Here, we studied 17 patients infected with Puumala virus that causes a mild form of hemorrhagic fever with renal syndrome (HFRS). Bronchial biopsies as well as longitudinal blood draws were obtained from the patients. During the acute stage of disease, a significant influx of MNPs expressing HLA-DR, CD11c or CD123 was detected in the patients’ bronchial tissue. In parallel, absolute numbers of MNPs were dramatically reduced in peripheral blood, coinciding with viremia. Expression of CCR7 on the remaining MNPs in blood suggested migration to peripheral and/or lymphoid tissues. Numbers of MNPs in blood subsequently normalized during the convalescent phase of the disease when viral RNA was no longer detectable in plasma. Finally, we exposed blood MNPs in vitro to Puumala virus, and demonstrated an induction of CCR7 expression on MNPs. In conclusion, the present study shows a marked redistribution of blood MNPs to the airways during acute hantavirus disease, a process that may underlie the local immune activation and contribute to immunopathogenesis in hantavirus-infected patients.


TH Open | 2018

Mesenteric Vein Thrombosis Following Platelet Transfusion in a Patient with Hemorrhagic Fever with Renal Syndrome: A Case Report

Anne-Marie Connolly-Andersen; Johan Rasmuson; Mikael Öman; Clas Ahlm

Viral hemorrhagic fevers (VHFs) are typically characterized by life-threatening thrombocytopenia and tendency to bleed. Still, there are gaps of knowledge regarding risks and benefits of platelet transfusion for patients with severe thrombocytopenia during VHF and other infectious diseases. 1 2 3 4 Hemorrhagic fever with renal syndrome (HFRS) is a mild rodent-borne VHF, caused by Puumala virus, endemic in central and northern Europe. The infection is characterized by fever, nausea, back- and headache, thrombocytopenia, and transient renal impairment. We have shown that HFRS is a risk factor for both arterial and venous thrombosis. 5 6 We here report a case of a patient with HFRS with prolonged thrombocytopenia who developed thrombosis shortly after receiving platelet transfusion.


Open Forum Infectious Diseases | 2017

Fatal Puumala Hantavirus Disease : Involvement of Complement Activation and Vascular Leakage in the Pathobiology

Tarja Sironen; Jussi Sane; Marja-Liisa Lokki; Seppo Meri; Leif C. Andersson; Timo Hautala; Heikki Kauma; Sakari Vuorinen; Johan Rasmuson; Magnus Evander; Clas Ahlm; Antti Vaheri

Abstract The case-fatality rate of hantavirus disease depends strongly on the causative hantavirus, ranging from 0.1% to 40%. However, the pathogenesis is not fully understood, and at present no licensed therapies exist. We describe fatal cases caused by Puumala hantavirus indicating involvement of complement activation and vascular leakage.


Chest | 2011

Presence of Activated Airway T Lymphocytes in Human Puumala Hantavirus Disease

Johan Rasmuson; Jamshid Pourazar; Mats Linderholm; Thomas Sandström; Anders Blomberg; Clas Ahlm


BMC Infectious Diseases | 2013

Cardiopulmonary involvement in Puumala hantavirus infection

Johan Rasmuson; Per Lindqvist; Karen Sörensen; Magnus Hedström; Anders Blomberg; Clas Ahlm


European Journal of Clinical Microbiology & Infectious Diseases | 2016

Cytotoxic immune responses in the lungs correlate to disease severity in patients with hantavirus infection

Johan Rasmuson; Jamshid Pourazar; Nahla Mohamed; Kristina Lejon; Magnus Evander; Anders Blomberg; Clas Ahlm


American Journal of Respiratory and Critical Care Medicine | 2015

Immunolocalisation Of Puumala Hantavirus In Human Endobronchial Biopsies

Gregory Rankin; Johan Rasmuson; Jamshid Pourazar; Anders Blomberg; Clas Ahlm


Archive | 2011

For Peer Review Hantavirus-specific IgA in saliva and viral antigen in the parotid gland in patients with hemorrhagic fever with renal syndrome

Johan Rasmuson; Charlotta Andersson; Clas Ahlm; Magnus Evander

Collaboration


Dive into the Johan Rasmuson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge